Self-guided

<5 minutes

Barrier Dysfunction, Type 2 Inflammation and Neuroimmune Dysregulation Interact to Drive the Pathophysiology of AD, Asthma, CRSwNP and EoE

Topic: Burden Of Disease Pathophysiology

Tags: Atopic dermatitis  CRSwNP  Qol  EoE  Asthma 

Barrier Dysfunction, Type 2 Inflammation and Neuroimmune Dysregulation Interact to Drive the Pathophysiology of AD, Asthma, CRSwNP and EoE

 

 

MAT-US-2204748 v1 P Exp. Date: 07/20/2024

Welcome to the ADVENT program website

ADVENT is a medical education program by Sanofi Genzyme and Regeneron. This website is intended only for health care professionals in the US only.

I AM A HEALTHCARE PROVIDER
I AM NOT A HEALTHCARE PROVIDER

ADVENT is a global medical education program by Sanofi Genzyme and Regeneron and is only intended for healthcare providers.

You are leaving the ADVENT program website

Sanofi Genzyme does not review or control the content of non–Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of the site’s content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non–Sanofi Genzyme website.

LEAVE THIS SITE GO BACK TO ADVENT PROGRAM